The top cardiac technology news item in March was the FDA clearing the MitraClip for use in heart failure patients with functional mitral regurgitation based on the very positive results of the COAPT Trial.
Related Most Popular Content:
Most Popular Cardiology Technology Content in February 2019
Most Popular Cardiology Technology Content in January 2019